Developing new care models through NHS vanguards

National Audit Office, July 2018

This report examines whether the NHS is well placed to get value for money from its investment in developing new care models through vanguards. In particular, it focuses on:

  • set up and management of the vanguard programme (Part One);
  • national support and evaluation (Part Two);
  • progress made by the vanguards (Part Three); and
  • readiness for the spread of these new care models (Part Four).

This report focuses primarily on the two types of vanguards which were designed to test integrated models of health and social care for a local population: integrated primary and acute care systems (PACs) and multispecialty community providers (MCPs). The report also covers the six enhanced health in care homes (EHCHs) vanguards and the 13 acute care collaborations (ACCs) vanguards. We excluded from our report the eight urgent and emergency care (UECs)vanguards, which were all moved to another part of NHS England after the first year.

Finds individual vanguards have made progress in implementing new models of care and there are early signs of a positive impact on emergency admissions. But the evaluation is not yet complete and, while NHS England expects to achieve savings, the long-term impact and sustainability of vanguards is still not proven.

Click here to view the report.

Advertisements

Learning from the vanguards: spreading and scaling up change

NHS Clinical Commissioners, February 2018

This briefing looks at what can be learned from the vanguards’ efforts to design, test and deliver a variety of scalable and replicable new care models. It shares the lessons that other organisations and partnerships can take from the vanguards’ experiences.

Click here to view this report.

Models of Care for High-Need, High-Cost Patients: An Evidence Synthesis

The Commonwealth Fund, November 2015

This report by the Commonwealth Fund describes research about clinical care models or care management programs implemented by health care provider organisations to improve outcomes and reduce costs for high-need, high-cost patients.

Click here to read the report.